Pharmaceutical Shares of Nordic Nanovector quadruple on high volumes in four days before profit taking took over, after it announced a definitive share exchange agreement to combine with Thor Medical, a fellow Norway-based privately held company focused on the production of alpha-emitting radionuclides for cancer treatment, in an all-share transaction. 10 June 2023